iHuman Inc. Files December 2025 6-K Report
Ticker: IH · Form: 6-K · Filed: Dec 29, 2025 · CIK: 1814423
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, reporting
Related Tickers: IH
TL;DR
iHuman Inc. (IH) filed its December 6-K, including a press release. No major financial updates, just routine reporting.
AI Summary
iHuman Inc. filed a Form 6-K on December 29, 2025, reporting for the month of December 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing provides an update on iHuman Inc.'s activities and disclosures for December 2025, which is important for investors to stay informed about the company's ongoing operations and reporting.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial information or material events.
Key Numbers
- 001-39591 — Commission File Number (Identifies the specific SEC filing for iHuman Inc.)
Key Players & Entities
- iHuman Inc. (company) — Registrant
- Vivien Weiwei Wang (person) — Director and Chief Financial Officer
- 001-39591 (dollar_amount) — Commission File Number
- 20251229 (dollar_amount) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country, files or makes public with any stock exchange on which its securities are traded, or distributes or makes public to its security holders.
What specific information is included in this Form 6-K filing?
This Form 6-K includes Exhibit 99.1, which is a Press Release, and is filed for the month of December 2025.
Who signed this Form 6-K on behalf of iHuman Inc.?
Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of iHuman Inc.
What is the principal executive office address of iHuman Inc.?
The principal executive offices are located at Tower 306, No. 86 Beiyuan Road, Chaoyang District, Beijing 100101, People's Republic of China.
Does iHuman Inc. file annual reports under Form 20-F or Form 40-F?
The filing indicates that iHuman Inc. files annual reports under Form 20-F.
Filing Stats: 150 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-12-29 07:33:02
Filing Documents
- tm2534405d1_6k.htm (6-K) — 10KB
- tm2534405d1_ex99-1.htm (EX-99.1) — 210KB
- tm2534405d1_ex99-1img001.jpg (GRAPHIC) — 2KB
- 0001104659-25-124502.txt ( ) — 224KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. iHuman Inc. By : /s/ Vivien Weiwei Wang Name : Vivien Weiwei Wang Title : Director and Chief Financial Officer Date: December 29 , 2025